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Abstract
Background: Obesity and asthma are an important public health problem in Saudi Arabia. An increasing body of  data supports 
the hypothesis that obesity is a risk factor for asthma. Asthma appears to be associated with low bone mineral density (BMD) 
due to long-term use of  corticosteroids. Studies recently showed that weight bearing exercise training can increase mineral bone 
density, reduce weight and improve metabolic control. 
Objective: The present study aimed to measure the effects of  treadmill walking exercises on bone mineral status and inflamma-
tory cytokines in obese asthmatic patients treated with long term intake of  corticosteroids. 
Methods: Eighty obese asthmatic patients of  both sexes, their age ranged from 41 to 53 years. Subjects were divided into two 
equal groups: training group (group A) received aerobic exercise training on treadmill for six months in addition to the medical 
treatment where, the control group (group B) received only the medical treatment. 
Results: The results of  this study indicated a significant increase in BMD of  the lumbar spine & the radius, serum calcium 
and high density lipoprotein cholesterol (HDL-c) & significant reduction in parathyroid hormone, leptin, tumor necrosis fac-
tor–alpha(TNF-α), interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-6 (IL-6), low density lipoprotein cholesterol (LDL-c), 
triglycerides (TG) and  body mass index (BMI) in group (A), while these changes were not significant in group (B).Also; there 
was a significant difference between both groups at the end of  the study. 
Conclusion: Treadmill walking exercise training is an effective treatment policy to improve bone mineral status and modulates 
inflammatory cytokines and blood lipids profile in obese asthmatic patients with long term intake of  corticosteroids.
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Introduction
Asthma and obesity are common disorders with a preva-
lence that has increased substantially over recent decades. 
Obesity is a growing worldwide problem that has reached 
epidemic proportions. The World Health Organization 
estimates that more than 600 million adults were obese 
in 20141. Asthma is also a major health problem, which is 
estimated to affect about 300 million persons worldwide, 
with the global prevalence of  asthma ranging from 1% to 
18% of  the general population2 and is expected to affect 
an additional 100 million people by 20253,4.
 
Obesity may not be only associated with lung mechanics, 
such as airway closure during tidal breathing and reduced 
expiratory residual capacity5, but also with a high expres-
sion of  certain inflammatory mediators, such as tumor 
necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and 
leptin6,7. Also, asthma and obesity can be associated with 
chronic low-grade systemic inflammation involving acute 
phase proteins such as C-reactive protein (CRP) and pro-
inflammatory cytokines such as IL-6, which may be driv-
en by adipose tissue inflammation8-12.
According to data from the Healthcare Cost and Utili-
zation Project, corticosteroids were the most common 
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cause of  drug-related complications, accounting for 10% 
of  such complications and 141,000 hospital stays in the 
United States in 200413.Corticosteroids-induced osteopo-
rosis results from suppression of  bone formation while 
bone resorption is promoted14. Moderate or high doses 
of  inhaled corticosteroids (ICS) are associated with in-
creased risk of  osteoporosis15. Long-term low-dose ICS 
use increases the rate of  bone marrow density (BMD) 
loss in patients with chronic obstructive pulmonary dis-
ease16.
 
Corticosteroids have detrimental effects on function and 
survival of  osteoblasts and osteocytes, and with the pro-
longation of  osteoclast survival, induce metabolic bone 
disease17. Inhaled corticosteroids are widely accepted for 
their potent anti-inflammatory effects in the lungs and 
low systemic activity18. The use of  ICS is the standard 
maintenance therapy in the management of  asthma19.
 
Obesity is also associated with less likelihood of  achiev-
ing well-controlled asthma and less-favorable response 
to current asthma therapy20,21 and Global Initiative for 
asthma (GINA) 2014 recommends weight loss for all 
obese asthmatics3. The present study aimed to measure 
the effects of  treadmill walking exercises on bone min-
eral status and inflammatory cytokines in obese asthmatic 
patients treated with long term intake of  corticosteroids.
Material and methods
Subjects
Eighty obese asthmatic patients of  both sexes (40 males 
& 40 females), their ages ranged between 41-53 years and 
their body mass index ranged between 30-37 kg/m2 were 
enrolled in the present randomized controlled trial. The 
chronicity of  the bronchial asthma was not less than 10 
years. Participants had been taking bronchodilator thera-
py in addition to inhaled beclomethasone dipropionate or 
budesonide in doses ranging from 1000 to 1600 μg/day 
for at least six months preceding the start of  the study. 
All participants were asked to read and sign an informed 
consent document prior to participation. Exclusion cri-
teria included endocrinal, renal, liver, cardiac disorders, 
diabetes and other chest disease rather than bronchial 
asthma, fractures occurring within the six months preced-
ing the start of  the study, disorders of  bone metabolism 
such as osteoporosis and pregnancy, lactation, inadequate 
contraceptive precautions, amenorrhea or a history of  ir-
regular menstrual cycles during the 12 months preceding 
the start of  the study and treatment with any medication 
likely to influence bone metabolism.
 
All the patients who participated in the study were non-
smokers and continued in their ordinary diet throughout 
the study. Following pre-training testing, a randomized 
block procedure was used to assign qualified participants 
into two equal groups; group (A) received treadmill walk-
ing exercise training .The second group (B) was asked not 
to participate in any structured exercise program for the 
duration of  the study. The CONSORT diagram outlin-
ing the details of  the screening, run-in and randomiza-
tion phases of  the study and reasons for participant ex-
clusion can be found in figure (1). Informed consent was 
obtained from all participants. This study was approved 
by the Scientific Research Ethical Committee, Faculty of  
Applied Medical Sciences at King Abdulaziz University. 
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Measurements
•  Bone mineral density measurements: Dual Energy 
X-RayAbsorptiometry ((DXA) GE Lunar Prodigy en-
CORE software version 8.80, GE Medical Systems, Mad-
ison WI) was used to assess the BMD of  lumbar spine 
(L2–L4) and the forearm (33% radius) sites assessed at 
baseline and after the eight month training period. Sub-
jects removed all metal and plastic before being posi-
tioned on the DXA table.
•  Chemical analysis: After fasting for 12 hours blood 
sample will be taken from each subject in clean plain tubes 
and for other diagnosis different types of  anticoagulant 
would be used such as K2EDTA, Lithium heparin, and 
Na2 Citrate. All tubes would be centrifuged and plasma 
separated stored frozen at -20° and used for estimation 
of  plasma tumor necrosis factor –alpha (TNF-α), inter-
leukin-2 (IL-2), interleukin-4 (IL-4), interleukin-6 (IL-6), 
leptin and plasma lipid profile included Triglycerides, high 
density lipoprotein cholesterol (HDL-c) and low density 
lipoprotein cholesterol (LDL-c). However, parathyroid 
hormone (PTH) and serum calcium were measured in se-
rum with an ELISA (Diagnostics Systems Laboratories, 
Inc., Webster, TX).
All measurements of  bone mineral density (BMD) of  
lumbar spine & radius, serum calcium, parathyroid hor-
mone, triglycerides, HDL-c, LDL-c, leptin, TNF-α, IL-2, 
IL-4, IL-6 and BMI were done before the starting of  the 
Figure (1) : Subjects screening and recruitment  CONSORT diagram.
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Following the previous evaluation , all patients were di-
vided randomly into the following groups:
• Group (A):  Forty obese asthmatic patients of  both 
sexes (23 males & 17 females), who received moderate 
intensity aerobic exercise training program. The training 
program consisted of  treadmill exercise of  progressive 
increasing intensity and frequency. The starting treadmill 
speed was 5 kilometer/hour and at 2 degrees angle of  
inclination. Then gradually increased at 2 minute inter-
vals until it reached the initial intensity of  60% of  the 
maximal heart rate. Then increased gradually until reach-
ing 80% of  the maximal heart rate by the end of  the six 
months. The duration of  each session was 30 minutes, in-
cluding warming up for 5 minutes, 20 minutes for the ac-
tive stage of  training and finally 5 minutes for the cooling 
down. This training was repeated three times per week 
for six months.
• Group (B):  Forty obese asthmatic patients of  both 
sexes (21 males & 19 females) were asked to maintain 
their ordinary current life style with the usual medical 
therapy for six months.
Statistical analysis
Mean values of  the investigated parameters was compared 
by student paired "t" test. While, the unpaired" test was 
be used to compare between the two groups (P<0.05).
Results
Both study groups were considered homogeneous re-
garding the demographic and baseline variables (table 1). 
Table (1): Mean value of baseline and demographic data for 
participants in both groups. 
  
  Mean ± SD Significance Group (A) Group(B) 
Age (year) 47.21±6.52 46.36±5.13 P >0.05 
Gender (male/female) 23/17 21/19 P >0.05 
Weight (kg) 70.63±6.17 73.18±6.22 P >0.05 
Height (cm) 169.53±6.71 171.21±6.85 P >0.05 
BMI (kg/m2) 32.45± 3.21 33.17± 3.42 P >0.05 
FVC (L) 2.52 ± 0.82 2.31 ± 0.70 P>0.05 
FEV1 (L) 1.35 ±  0.65 1.28 ± 0.59 P>0.05 
FEV1/FVC (%) 48.77 ± 7.86 49.12 ± 8.23 P>0.05 
MVV (L/minute) 47.64 ± 9.14 44.51 ±10.12 P>0.05 
 
BMI = Body mass index; FVC = forced vital capacity; FEV1= forced expiratory volume in the first 
second; FEV1/FVC = Ratio between forced expiratory volume in the first second and forced vital capacity; MVV= 
Maximum voluntary ventilation. 
The results of  this study indicated a significant increase 
in BMD of  the lumbar spine & the radius, serum cal-
cium and HDL & significant reduction in parathyroid 
hormone, leptin, LDL, TG, TNF-α, IL-2, IL-4, IL-6 and 
BMI in group (A), while these changes were not signifi-
cant in group (B) (Table 2 and 3). 
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Table (2): Mean value and significance of serum calcium and  
parathyroid hormone, BMD of lumbar spine, BMD of radius, HDL-c,  
LDL-c, TG, BMI, Leptin, TNF-α, IL-2, IL-4 and IL-6 in group (A)  
before and at the end of the study. 
 
  Mean ± SD T-value Significance 
Before After 
Serum 
Calcium(ng/dl) 8.67 ±1.18 10.61± 1.17* 6.41 P <0.05 
Parathyroid 




120.96± 9.17 150.32± 8.37* 8.23 P <0.05 
BMD of 
radius(mg/cm) 266.62± 12.37 311.36± 11.35* 9.17 
P <0.05 
HDL-c  (mg/dl) 34.73 ± 5.61 37.92 ± 4.58* 8.64 P <0.05 
LDL-c  (mg/dl 133.71 ± 13.21 120.32 ± 11.45* 8.91 P <0.05 
TG  (mg/dl) 155.36 ± 12.64 127.73 ± 11.27* 10.20 P <0.05 
BMI (Kg/m2) 35.15 4.63  4.4831.41* 9.21 P <0.05 
Leptin    (Ng/ml) 5.4340.32 4.4635.21* 7.13 P <0.05 
TNF-α (pg/mL) 5.71± 1.76 4.22 ± 1.14* 6.52 P <0.05 
IL-2 (pg/mL) 7.86 ± 2.05 4.42 ± 1.57* 5.32 P <0.05 
IL-4(pg/mL) 5.32± 1.51 3.41± 1.26* 5.40 P <0.05 
IL-6 (pg/mL) 8.76 ± 2.32 5.34 ± 1.85* 6.19 P <0.05 
 
BMD: Bone marrow density; HDL-c: High density lipoprotein cholesterol; LDL-c: Low density lipoprotein 
cholesterol;    TG: Triglyceride; BMI: Body Mass index; TNF- α = tumor necrosis factor – alpha; IL-2: Interleukin-
2; IL-4: Interleukin-4; IL-6: Interleukin-6;(*): indicates a significant difference, P < 0.05.    
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Table (3): Mean value and significance of serum calcium and parathyroid 
hormone, BMD of lumbar spine, BMD of radius, HDL-c, LDL-c, TG, BMI, 
Leptin, TNF-α, IL-2, IL-4 and IL-6  in group (B) before and  
at the end of the study. 
 
  Mean ± SD T-value Significance 
Before After 
Serum 
Calcium(ng/dl) 8.75± 1.23 8.96 ±1.19 0.63 
P >0.05 
Parathyroid 
Hormone (ng/dl) 14.26 ±2.18 14.72 ±2.11 0.58 
P >0.05 
BMD of lumbar 
spine (mg/cm) 122.16± 7.98 120.47± 7.87 1.85 P >0.05 
BMD of 
radius(mg/cm) 268.12± 10.21 265.96± 9.73 1.92 
P >0.05 
HDL-c  (mg/dl) 34.86 ± 5.28 34.12 ± 5.13 0.87 P >0.05 
LDL-c  (mg/dl 132.94 ± 12.17 133.34 ± 
12.05 
0.68 P >0.05 
TG  (mg/dl) 154.93 ± 11.88 155.15 ± 
11.64 
0.51 P >0.05 
BMI (Kg/m2) 34.78 4.21 34.88 4.12 0.45 P >0.05 
Leptin    (Ng/ml)   39.98 ± 4.75   40.12 ± 
3.64 
0.51 P >0.05 
TNF-α (pg/mL) 5.66± 1.45 5.87 ± 1.33 0.63 P >0.05 
IL-2 (pg/mL) 7.72 ± 2.24 7.93 ± 2.06 0.42 P >0.05 
IL-4(pg/mL) 5.21± 1.63 5.35 ± 1.41 0.64 P >0.05 
IL-6 (pg/mL) 8.67 ± 2.01 8.82 ± 2.13 0.53 P >0.05 
 
BMD: Bone marrow density; HDL-c: High density lipoprotein cholesterol; LDL-c: Low density lipoprotein 
cholesterol;    TG: Triglyceride ; BMI: Body Mass index; TNF- α = tumor necrosis factor – alpha; IL-2 : Interleukin-
2; IL-4 : Interleukin-4; IL-6 : Interleukin-6.  
Also; there was a significant difference between both groups at the end of  the study (Table 4).
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Table (4): Mean value and significance of serum calcium and parathyroid 
hormone, BMD of lumbar spine, BMD of radius, HDL-c, LDL-c, TG, BMI, 
Leptin, TNF-α, IL-2, IL-4 and IL-6  in group (A) and group (B) at the end of the 
study. 
  
  Mean ± SD T-value Significance 
Group (A) Group (B) 
 
BMD: Bone marrow density; HDL-c: High density lipoprotein cholesterol; LDL-c: Low density lipoprotein 
cholesterol;    TG: Triglyceride; BMI: Body Mass index; TNF- α = tumor necrosis factor – alpha; IL-2: 
Interleukin-2; IL-4: Interleukin-4; IL-6: Interleukin-6; (*): indicates a significant difference, P < 0.05.    
 Serum 









HDL-c  (mg/dl) 37.92 ± 4.58* 34.12 ± 
5.13 
8.68 P <0.05 
BMD of lumbar 
spine (mg/cm) 150.32± 8.37* 
120.47± 
7.87 8.57 P <0.05 
BMD of 




LDL-c  (mg/dl 120.32 ± 11.45* 133.34 ± 
12.05 
8.63 P <0.05 
TG  (mg/dl) 127.73 ± 11.27* 155.15 ± 
11.64 
9.11 P <0.05 
BMI (Kg/m2) 4.4831.41* 34.88 4.12 9.42 P <0.05 
Leptin    (Ng/ml) 4.4635.21*   40.12 ± 3.64 7.53 
P <0.05 
TNF-α (pg/mL) 4.22 ± 1.14* 5.87 ± 1.33 6.65 
P <0.05 
IL-2 (pg/mL) 4.42 ± 1.57* 7.93 ± 2.06 5.71 
P <0.05 
IL-4(pg/mL) 3.41± 1.26* 5.35 ± 1.41 5.58 
P <0.05 
IL-6 (pg/mL) 5.34 ± 1.85* 8.82 ± 2.13 6.46 
     P <0.05 
Table (4): ean value and significance of serum calcium and parathyroid 
hormone, B D of lumbar spine, B D of radius, HDL-c, LDL-c, TG, B I, 
Leptin, TNF-α, IL-2, IL-4 and IL-6  in group (A) and group (B) at the end of the 
study. 
  
  Mean ± SD T-value Significance 
Group (A) Group (B) 
 
BMD: Bone marrow density; HDL-c: High density lipoprotein cholesterol; LDL-c: Low density lipoprotein 
cholesterol;    TG: Triglyceride; BMI: Body Mass index; TNF- α = tumor necrosis factor – alpha; IL-2: 
Interleukin-2; IL-4: Interleukin-4; IL-6: Interleukin-6; (*): indicates a significant difference, P < 0.05.    
 Serum 









HDL-c  (mg/dl) 37.92 ± 4.58* 34.12 ± 
5.13 
8.68 P <0.05 
BMD of lumbar 
spine (mg/cm) 150.32± 8.37* 
120.47± 
7.87 8.57 P <0.05 
BMD of 




LDL-c  (mg/dl 120.32 ± 11.45* 133.34 ± 
12.05 
8.63 P <0.05 
TG  (mg/dl) 127.73 ± 11.27* 155.15 ± 
11.64 
9.11 P <0.05 
BMI (Kg/m2) 4.4831.41* 34.88 4.12 9.42 P <0.05 
Leptin    (Ng/ml) 4.4635.21*   40.12 ± 3.64 7.53 
P <0.05 
TNF-α (pg/mL) 4.22 ± 1.14* 5.87 ± 1.33 6.65 
P <0.05 
IL-2 (pg/mL) 4.42 ± 1.57* 7.93 ± 2.06 5.71 
P <0.05 
IL-4(pg/mL) 3.41± 1.26* 5.35 ± 1.41 5.58 
P <0.05 
IL-6 (pg/mL) 5.34 ± 1.85* 8.82 ± 2.13 6.46 
     P <0.05 
Table (4): Mean value and significance of serum calcium and parathyroid 
hormone, BMD of lumbar spine, BMD of radius, HDL-c, LDL-c, TG, BMI, 
Leptin, TNF-α, IL-2, IL-4 and IL-6  in group (A) and group (B) at the end of the 
study. 
  
  Mean ± SD T-value Significance 
Group (A) Group (B) 
 
BMD: Bone marrow density; HDL-c: High density lipoprotein cholesterol; LDL-c: Low density lipoprotein 
cholesterol;  TG: Triglyceride; BMI: Body Mas  index; TNF- α = tumor necrosis factor – alpha; IL-2: 
Interleukin-2; IL-4: Interleukin-4; IL-6: Interleukin-6; (*): indicates a signif cant difference, P < 0.05.   
 Serum 





Hormone (ng/dl) 12.26± 2.34* 
14.72 
±2.1  6.76 
P <0.05 
HDL-c  (mg/dl) 37.92 ± 4.58* 34.12 ± 
5.13 
8.68 P <0.05 
BMD of lumbar 
spine (mg/cm) 150.32± 8.37* 
120.47± 
7.87 8.57 P <0.05 
BMD of 




LDL-c  (mg/dl 120.32 ± 1 .45* 13 .34 ± 
12.05 
8.63 P <0.05 
TG  (mg/dl) 127.73 ± 1 .27* 15 .15 ± 
1 .64 
9.1  P <0.05 
BMI (Kg/m2) 4.4831.41* 34.8  4.12 9.42 P <0.05 
Leptin  (Ng/ml) 4.4635.21*   40.12 ± 3.64 7.53 
P <0.05 
TNF-α (pg/mL) 4.2  ± 1.14* 5.87 ± 1.3 6.65 
P <0.05 
IL-2 (pg/mL) 4.42 ± 1.57* 7.93 ± 2.06 5.71 
P <0.05 
IL-4(pg/mL) 3.41± 1.26* 5.35 ± 1.41 5.58 
P <0.05 
IL-6 (pg/mL) 5.34 ± 1.85* 8.82 ± 2.13 6.46 
    P <0.05 
Discussion
As asthma appears to be associated with low bone miner-
al density (BMD) due to long-term use of  corticosteroids 
and studies recently showed that weight bearing exercise 
training can increase mineral bone density, reduce weight 
and improve metabolic control, so this study aimed to 
evaluate the efficacy of  treadmill walking exercises on 
markers of  bone metabolism and inflammatory cyto-
kines in obese asthmatic patients with long term intake 
of  corticosteroids. The results of  this study indicated a 
significant increase in BMD of  the lumbar spine & the 
radius, serum calcium and HDL-c & significant reduction 
in parathyroid hormone, leptin, TNF-α, IL-2, IL-4, IL-6, 
LDL-c, TG and  BMI in group (A), while these changes 
were not significant in group (B) which means that tread-
mill walking exercise training is an effective treatment 
policy to improve bone mineral status and modulates in-
flammatory cytokines and blood lipids profile in obese 
asthmatic patients with long term intake of  corticoste-
roids , these results agreed with many previous studies in 
this area.
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Lester etal. stated that training interventions of  longer du-
ration (6–36 months) have consistently reported positive 
bone mineral density increases, whereas those of  shorter 
durations (< 6 months) have failed to show similar adap-
tations22. Also, Nordstrom etal. reported that athletes who 
participate in weight-bearing activities have higher BMD 
than sedentary controls23. While, Bonaiuti et al. stated 
that all prescribed exercise programs, including aerobic 
exercise, resistance exercises or walking are effective at 
1 year or more in slowing loss of  bone marrow density. 
Fast walking is recommended as the best prevention and 
treatment strategy for osteoporosis in postmenopausal 
women as it is most similar to activities of  daily living and 
may produce the greatest compliance24. However, Hind 
et al. reported that regular weight-bearing exercise ses-
sions, two to three times weekly, over a period of  at least 
6 months in pre- or early pubertal children with cystic 
fibrosis improves BMD25. While, Remes et al. said that 
physical activity is an important factor in attaining peak 
bone mass26. Also, Lin et al. stated that weight-bearing 
exercise had a greater positive effect on BMD than the 
non-weight-bearing exercise27. Moreover, Douchi et al. 
confirmed that lumbar spine BMD increased significantly 
in individual studies of  strength training with/without 
endurance exercise training28. Finally, weight bearing ex-
ercise is universally recognized as a major and effective 
prophylaxis against osteoporosis, to firstly stimulate bone 
accretion during growth; secondly, to stimulate bone ac-
cretion once bone loss has occurred and thirdly, to pre-
vent bone loss25.
 
The possible mechanism by which exercise maintains the 
skeletal integrity are: changes in the biochemical struc-
ture of  the blood by altering the level of  its component 
which has a role in the integrity of  normal skeletal and 
mechanical load of  the exercise which can modify and 
increase bone mass. The rise in serum calcium is mainly 
due to the effects of  exercise induced acidosis. So, when 
the parathyroid hormone falls the excess hydrogen ions 
reversibly displace calcium ions from imidazole groups 
of  the albumin molecule, thus causing the serum calcium 
to rise29. The increase in bone mineral density after exer-
cise may be due to increase in serum calcium associated 
with decreased parathyroid hormone following exercise 
training30.
Concerning the inflammatory cytokines, the mean values 
of  leptin, TNF-α, IL-2, IL-4 and IL-6 were significantly 
decreased after aerobic exercise training. These results are 
in line with many previous studies, Dekker et al. stated 
that a 12-week exercise intervention resulted in a signifi-
cant decrease in circulating IL-6 in subjects with type 2 
diabetes mellitus who underwent an exercise program 
without weight loss31. Also, Mikkelsen et al. proved that 
life-long endurance exercise was associated with a low-
er level of  the inflammatory markers CRP and IL-6 in 
elderly subjects32. While, Sugawara et al. concluded that 
the levels of  elevated inflammatory cytokines decreased 
significantly after intervention with an anti-inflamma-
tory nutrition combined with the low-intensity exercise 
in  stable elderly COPD patients33. In addition, there is 
evidence of  lowered IL-6 and TNF-α after prolonged ex-
ercise in obese women34 and decreased TNF-α after 12 
weeks of  aerobic exercise in patients with heart disease 35. 
Moreover, in obese postmenopausal women with type 2 
diabetes, 14 weeks of  aerobic exercise decreased CRP by 
15% and marginally decreased IL-6 (p=0.07)36. Likewise, 
12 week of  exercise reduced IL-18 levels by 17.5% in pa-
tients with metabolic syndrome37.
 
The exact mechanisms by which physical activity may 
reduce inflammation are not entirely understood, there 
is some data pointing to factors that may contribute to 
an effect of  repeated bouts of  muscle contraction lead-
ing to improvements in inflammatory status over time38. 
Exercise training-induced improvements in inflammatory 
status may also result from the modulation of  intracellu-
lar signaling pathways and cellular function that are medi-
ated by nitric oxide (NO) and ROS39. However, physical 
activity may lower leptin concentrations not only due to 
the decreased body fat mass, but potentially through an 
increase in leptin sensitivity40.
 
Regarding blood lipid profile, our results proved that aer-
obic exercise training resulted in significant increase in 
HDL-c and significant reduction in LDL-c and TG , these 
results are in line with many previous studies as Bounds 
and colleagues stated that exercise training resulted in an 
increase in HDL-c (10.7%) and a concomitant fall in tri-
glyceride (-25%) and total cholesterol (-3.5%)41. Where, 
exercise-induced increases in HDL-c and decreases in tri-
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glyceride are similar in hyper-and normo-cholesterolemic 
men and may be mediated, at least in part, by an increase 
in lipoprotein lipase activity42. However, aerobic exercise 
is efficacious for increasing HDL-C and decreasing TC, 
LDL-C, and TG in women43.
 
The current study has important strengths and limita-
tions. The major strength is the supervised nature of  the 
study. Supervising physical activity removes the need to 
question compliance or to rely on activity questionnaires. 
Further, all exercise sessions were supervised and adher-
ence to activities was essentially 100%. Moreover, the 
study was randomized; hence, we can extrapolate adher-
ence to the general population. In the other hand, the 
major limitation is the small sample size in both groups 
may limit the possibility of  generalization of  the find-
ings in the present study. Finally, within the limit of  this 
study, treadmill walking exercise training is an effective 
treatment policy to modulate bone mineral status, in-
flammatory cytokines and blood lipids profile in obese 
patients with bronchial asthma with long term intake of  
corticosteroids. Further researches are needed to explore 
the impact of   exercise training upon quality of  life and 




Treadmill walking exercise training is an effective treat-
ment policy to modulate bone mineral status, inflamma-
tory cytokines and blood lipids profile in obese patients 
with bronchial asthma with long term intake of  cortico-
steroids.
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